Most Popular Video

Adidas launches miCoach FitSmart     Wed, 9 Jul '14 | 11:25 AM ET

Paul Gaudio, Adidas general manager, introduces the "miCoach FitSmart." Adidas' new wearable smartband designed to aid users to reach their fitness goals and help athletes improve.

Discussing the resilient U.S. stock market and global growth strategies, with Katie Stockton, BTIG; Doug Gordon, Russell Investments; Ron Weiner, RDM Financial Group; and Kenny Polcari, O'Neil Securities.

Earnings Squad: NFLX, CMG & UTX     Mon, 21 Jul '14 | 2:25 PM ET

CNBC's Melissa Lee, Dominic Chu and trader Stephanie Link, preview the earnings for Netflix, Chipotle and United Technologies.

The big bubble debate     Mon, 21 Jul '14 | 2:02 PM ET

John Hailer, Natixis Global Asset Management president & CEO, weighs in on Janet Yellen's statement that she is sticking to the Greenspan-Bernanke policy and will not use interest rates to curtail asset bubbles, and discusses if he sees any bubbles right now.

US companies in Russia     Mon, 21 Jul '14 | 1:23 PM ET

CNBC's Steve Liesman reports which U.S. companies do business in Russia, and the relationship between Russian President Vladimir Putin and these businesses.

FMHR Final Trade: NMBR, HAL & more     Mon, 21 Jul '14 | 12:59 PM ET

The FMHR traders reveal their final trades of the hour, including the play on shares of Nimble Storage and Ingersoll-Rand.

Herb Greenberg, CNBC contributor, shares his thoughts on Bill Ackman's comments that Herbalife is a fraud. Let's not forget this is about the business model, says Greenberg.

Ackman: Herbalife is going to collapse     Mon, 21 Jul '14 | 12:45 PM ET
Bill Ackman

Pershing Square's Bill Ackman says he'll show evidence that Herbalife is a massive fraud.

Bill Ackman, Pershing Square, explains why he is not upping his bid for Allergan. The market clearly thinks the chance of Valeant buying Allergan has gone up, says Ackman.

Buy Apple ahead of earnings: Analyst     Mon, 21 Jul '14 | 12:10 PM ET

Alex Gauna, JPM Securities explains why he is upgrading Apple to a buy and placing a price target on the stock of $135 per share.

CNBC's Bob Pisani and Art Cashin, of UBS, discuss low volume in the market, and the market's response to geopolitical tensions in Ukraine and Israel.

Bull vs. bear: Netflix     Mon, 21 Jul '14 | 12:18 PM ET

Fast Money traders Mike Murphy and Stephanie Link debate the play on the streaming giant.

Charlie Bobrinskoy, Ariel investment vice chairman, waves the red flag on tech names that are overvalued.

Analyst ups target on Apple     Mon, 21 Jul '14 | 11:29 AM ET

With Apple set to report its quarterly earnings tomorrow, Steven Milunovich, UBS, explains why he is raising his price target on the tech giant.

CNBC's Bob Pisani looks at how the U.S. stock market moved while President Obama spoke on geopolitical events in Ukraine and the Middle East.

Frustration for families of MH17     Mon, 21 Jul '14 | 10:58 AM ET

NBC's Katy Tur reports anger is intensifying over the handling of the crash site of MH17, and the victims' families are growing increasingly frustrated.

Cashin: Markets 'stroll' to safety     Mon, 21 Jul '14 | 10:49 AM ET

Art Cashin, UBS director of floor operations, discusses how the market is reacting to the possibility of enhanced Russian sanctions.

British PM speaks to Putin: Report     Mon, 21 Jul '14 | 10:48 AM ET

CNBC's Michelle Caruso-Cabrera reports U.K. Prime Minister David Cameron has spoken with Vladimir Putin and has advised him to use his influence to allow investigators to the crash scene.

Discussing the escalating tensions overseas and what it means for the global markets, with John Rutledge, Safanad chief investment strategist.

Do Russians still support Putin?     Mon, 21 Jul '14 | 10:04 AM ET

NBC's Jim Maceda discuss how Russian citizens on the ground are reacting to the tragedy of MH17 and if they still support Vladimir Putin.

CNBC's Jim Cramer explains why he is watching shares of Microsoft.

Faber Report: Allergan vs. Valeant     Mon, 21 Jul '14 | 9:44 AM ET

CNBC's David Faber reports Allergan is cutting 13 percent of its workforce and Valeant complains to the SEC and Canadian regulators about Allergan statements.

Pisani's market open: Earnings so far     Mon, 21 Jul '14 | 9:40 AM ET

CNBC's Bob Pisani looks at the busy earnings week ahead and discusses the problems with regional banks.

Cramer's Mad Dash: GoPro stays hot     Mon, 21 Jul '14 | 9:28 AM ET

Jim Cramer explains what to watch ahead of the open, including why GoPro will go higher and reveals what will cause the stock to explode.

Cramer: Yum lost focus     Mon, 21 Jul '14 | 9:15 AM ET

CNBC's Jim Cramer and David Faber discuss how the stocks of McDonald's and Yum Brands are reacting to the shutdown of a Shanghai meat supplier used by both companies; also, problems for the Campbell Soup Company.

Elliott pushes to break up EMC     Mon, 21 Jul '14 | 9:10 AM ET

CNBC's David Faber reports activist investor Elliot Management reportedly has taken and more than $1 billion stake in EMC. And Allergan announces plans to cut 1,500 jobs as it continues fighting a takeover from Valeant.

Shock turns to anger over MH17     Mon, 21 Jul '14 | 9:07 AM ET

Anger is rising over the handling of the remains of Malaysia Airlines Flight MH17, reports NBC's Miguel Almaguer.

Hamas kidnaps Israeli soldier: Report     Mon, 21 Jul '14 | 9:05 AM ET

NBC's Martin Fletcher reports Israeli airstrikes are pounding Gaza again today and more than 500 Palestinians have been killed since the beginning of the offensive, and Hamas announced they have kidnapped an Israeli soldier.

Cramer: Halliburton underrated     Mon, 21 Jul '14 | 9:01 AM ET

The "Squawk on the Street" news team preview the busy earnings week and if geopolitical concerns could break the market.

Cramer's stocks to watch: AGN & VRX     Mon, 21 Jul '14 | 8:53 AM ET

CNBC's Jim Cramer shares his thoughts on the feud between Allergan and Valeant, and weighs in on how a slowdown in Europe would likely impact U.S. markets.